A recent study published in JAMA Pediatrics found the HPV vaccine to be highly effective 17 years after its introduction.
According to the study, the vaccine continues to provide strong protection for young women, even for those who did not complete the full series of doses.
Human papillomavirus (HPV) is the most common sexually transmitted infection worldwide, with low-risk types causing genital warts and high-risk types linked to various cancers.
HPV contributes to roughly 630,000 new cancer cases each year, with HPV-16 and -18 responsible for 71% of cervical cancers and 87% of anal cancers.
Author's summary: HPV vaccine remains highly effective after 17 years.